LaNova Medicines logo — Care for life. Dedicate to innovation.

LaNova Medicines

Care for life. Dedicate to innovation.

Founded 2019 China Shanghai, China 15 employees Series C Total: $883.00M Health Care, Pharmaceutical

General Information

Company Name LaNova Medicines
Founded Year 2019
Location China Shanghai, China
Employees 15
Industries Health Care, Pharmaceutical
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with LaNova Medicines. To contact LaNova Medicines, visit lanovamedicines.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About LaNova Medicines

Founded in 2019 in Shanghai, China, LaNova Medicines is a clinical-stage biotechnology company committed to the discovery and development of novel biologic drugs for cancer treatment. Led by industry veterans with a strong passion for innovation, we aim to operate as an R&D engine and deliver transformative medicines to address the unmet clinical needs of cancer patients. Leveraging our proprietary technology platforms and deep understanding of the tumor microenvironment. we have built a differentiated pipeline of products and are striving to progress our programs toward the clinic.

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series C CNY318.00M 1
Qiming Venture Partners
01 Jul 2024
Series B Undisclosed 4
Qiming Venture Partners, LC Ventures +2
28 Jun 2022
Series A Undisclosed 1
Asymchem Laboratories (Tianjin)
16 Sep 2021
Series A CNY565.00M 4
Qiming Venture Partners, Boyuan Capital +2
01 Jan 2021
Series A Undisclosed 4
Hony Capital, 盈科创新资产管理有限公司 +2
01 Jul 2020
Seed Round Undisclosed 1
盈科创新资产管理有限公司
01 Apr 2020
Angel Round Undisclosed 1
Tigermed
01 Dec 2019

LaNova Medicines Alternatives & Competitors

LaNova Medicines vs

Innovation, in Expedition

Series C
24 employees
Biotechnology, Health Care
LaNova Medicines vs
Aura Biosciences
Aura Biosciences United States

Aura Biosciences is a clinical-stage biotechnology company developing virus-like drug conjugates (VD...

Post-IPO Equity
113 employees
Biotechnology, Health Care
LaNova Medicines vs
Apollomics
Apollomics United States

We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...

Post-IPO Equity
26 employees
Biotechnology, Health Care

FAQ About LaNova Medicines

Care for life. Dedicate to innovation.
LaNova Medicines was founded in 2019.
LaNova Medicines is headquartered in Shanghai, China.
LaNova Medicines operates in Health Care and Pharmaceutical.
LaNova Medicines has approximately 15 employees.
LaNova Medicines has completed 7 funding rounds, raising a total of $883.00M. The latest funding stage is Series C.
Top alternatives and competitors to LaNova Medicines include GenFleet Therapeutics, Aura Biosciences, Apollomics, Everest Medicines, Zenith Epigenetics Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LaNova Medicines and GenFleet Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for LaNova Medicines, https://bouncewatch.com/company/lanova-medicines, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes